Richard B. Parsons, PhD, (PhD in biochemistry, University of Birmingham) was appointed as a lecturer in the Institute of Pharmaceutical Science, King’s College London in 2008. His major research interest is energy metabolism in Parkinson’s disease, making several seminal contributions to our understanding of the role of nicotinamide metabolism in neuronal survival and synapse formation. Dr. Parsons has extensive research expertise, most notably in the production and use of genetically-modified cell-lines and Drosophila for the elucidation of protein function in cell function and disease, the use of patient post-mortem samples for analysis of protein function, and the biochemical assessment of mitochondrial function.

He has presented his research at numerous national and international conferences, and is regularly invited to present seminars both in European and non-European Universities. He is a member of the Editorial Advisory Board of the Biochemical Journal, and is a member of the Biochemical Society and the International Neurotoxicology Society.